Evidence of platelet activation during treatment with a GPIIb/IIIa antagonist in patients presenting with acute coronary syndromes
- 25 October 2000
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 36 (5) , 1514-1519
- https://doi.org/10.1016/s0735-1097(00)00919-0
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Oral Glycoprotein IIb/IIIa Inhibition With Orbofiban in Patients With Unstable Coronary Syndromes (OPUS-TIMI 16) TrialCirculation, 2000
- The therapeutic use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromesExpert Opinion on Investigational Drugs, 1999
- Clinical Outcomes of Therapeutic Agents That Block the Platelet Glycoprotein IIb/IIIa Integrin in Ischemic Heart DiseaseCirculation, 1998
- A Sequence within the Cytoplasmic Tail of GpIIb Independently Activates Platelet Aggregation and Thromboxane SynthesisPublished by Elsevier ,1998
- Integrin αIIbβ3 and Platelet FunctionThrombosis and Haemostasis, 1997
- The pharmacology of the integrinsMedicinal Research Reviews, 1994
- Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction.Circulation, 1988
- Platelet Activation in Unstable Coronary DiseaseNew England Journal of Medicine, 1986
- Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death.Circulation, 1986
- Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion.Circulation, 1985